the findings show that the new h2-receptor antagonist famotidine , administered as a single evening dose , significantly speeds the healing of benign gastric ulcers and that it is a safe and highly effective treatment of gastric ulceration .
C0015620
h2-receptor antagonist famotidine
C0038358
gastric ulceration